Bridgeway Capital Management, LLC Celldex Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.61 - $13.41 $80,822 - $673,182	-50,200 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.55 - $3.07 $42,005 - $83,197	-27,100 Reduced 35.06%	50,200 $83,000
Q4 2019 Feb 14, 2020	SELL	$2.11 - $2.8 $147,700 - $196,000	-70,000 Reduced 47.52%	77,300 $172,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.75 $118,079 - $158,400	-57,600 Reduced 28.11%	147,300 $314,000
Q2 2019 Aug 14, 2019	BUY	$2.43 - $5.09 $197,316 - $413,308	81,200 Added 65.64%	204,900 $549,000
Q1 2019 May 15, 2019	BUY	$3.45 - $10.35 $426,765 - $1.28 Million	123,700 New	123,700 $609,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.